Background/Aims The identification of factors that lead to CD8+ T cell dysfunction within the tumor microenvironment (TME) holds great promise for the development of innovative immunotherapies. However, the mechanisms underlying the exhausted phenotype of CD8+ T cells infiltrating early-stage hepatocellular carcinoma (HCC) tumors remain unclear.
Methods Single-cell RNA sequencing was performed using a murine HCC model. Flow cytometry and additional experimental approaches were employed to investigate the mechanisms of CD8+ T cell exhaustion.
Results CD8+ T cells infiltrating early-stage HCC exhibited a functionally exhausted phenotype, which escalated with HCC progression. At early stages of HCC, the TME was characterized by significant iron accumulation. Moreover, tumor-infiltrating CD8+ T cells in murine HCC exhibited higher levels of intracellular ferrous iron compared to splenic CD8+ T. This excessive iron led to increased lipid peroxide levels and impaired the effector function of CD8+ T cells. Mechanistically, CD36 upregulated the iron uptake protein transferrin receptor 1 (TfR1) by mediating the activation of oxidized low-density lipoprotein (oxLDL)-p38-CEBPB axis. Depletion of CD36 in CD8+ T cells inhibited the upregulation of TfR1 and the increase of iron levels. Furthermore, constitutively activated nuclear factor erythroid 2-related factor 2 (NRF2) effectively suppressed lipid peroxidation, thereby preserving the effector functions of intratumoral CD8+ T cells and ultimately inhibiting tumor growth.
Conclusions Our findings reveal a previously unidentified mechanism mediated by CD36 that regulates the progressive dysfunction of CD8+ T cells in early HCC TME and provide a potential novel therapeutic approach to restore T cell function.
Citations
Citations to this article as recorded by
The dual role of CD36 in cancer: from lipid metabolism to tumor microenvironment regulation Yixuan Yao, Yanyuan Fang, Bin Yuan, Jing Yang Molecular Biology Reports.2025;[Epub] CrossRef
Oxidative stress in cancer: from tumor and microenvironment remodeling to therapeutic frontiers Xisong Liang, Jiadi Weng, Zhongyi You, Yang Wang, Jie Wen, Zhiwei Xia, Shaorong Huang, Peng Luo, Quan Cheng Molecular Cancer.2025;[Epub] CrossRef
Targeting Ferroptosis Restores the Antiviral Activity of CD8+ T Cells During Chronic Hepatitis B Virus Infection Haohao Li, Su Xiao, Chenxin Huo, Shasha Yang, Jun Wang, Xinxing Lan, Menghua Li, Lizhi Shi, Li Zhuo, Jian Zhang, Huajun Zhao, Qiuju Han Cellular and Molecular Gastroenterology and Hepatology.2025; 19(12): 101612. CrossRef
Correspondence to editorial “Targeting CD36 to reinvigorate CD8+ T Cells in early-stage hepatocellular carcinoma” Yifei Qin, Peng Lin, Huijie Bian, Zhi-Nan Chen, Jiao Wu Clinical and Molecular Hepatology.2025;[Epub] CrossRef
Targeting lipid metabolism to enhance cancer immunotherapy Dan Zhao, Lei Wu, Yongsheng Li Biochimica et Biophysica Acta (BBA) - Reviews on Cancer.2025; 1880(5): 189416. CrossRef
Establishment of an anaplastic stratification signature for gastric cancer based on diverse regulated cell-death Shaofei Chen, Zhiyong Wang Frontiers in Immunology.2025;[Epub] CrossRef
Mitochondrial lipid metabolism in tumor immunosurveillance and evasion Ana Belén Plata-Gómez, Weixin Chen, Ping-Chih Ho, Guang Sheng Ling Trends in Immunology.2025;[Epub] CrossRef
The Role of Ferroptosis on the Pathogenesis and Therapy of Hepatocellular Carcinoma Xue Wang, Jinhong Wang, Wentong Li, Shanming Sun Cell Biochemistry and Function.2025;[Epub] CrossRef
Innate immunity in tumors: roles and therapeutic targets Songze Leng, Yuyue Ren, Yaoyao Tian, Weiwei Zhao, Yue Mou, Xingyu Chen, Hong Zhou, Wei Wang Frontiers in Immunology.2025;[Epub] CrossRef
Reply to correspondence on “UBE2S: A novel driver of HIF-1alpha-induced metabolic reprogramming in hepatocellular carcinoma” Martina Mang Leng Lei, Terence Kin Wah Lee Clinical and Molecular Hepatology.2025; 31(1): e119. CrossRef
Background/Aims Ubiquitination is widely involved in the progression of hepatocellular carcinoma (HCC) by regulating various cellular processes. However, systematic strategies for screening core ubiquitin-related genes, clarifying their functions and mechanisms, and ultimately developing potential therapeutics for patients with HCC are still lacking.
Methods Cox and LASSO regression analyses were performed to construct a ubiquitin-related gene prediction model for HCC. Loss- and gain-of-function studies, transcriptomic and metabolomics analysis were used to explore the function and mechanism of UBE2S on HCC cell glycolysis and growth.
Results Based on 1,423 ubiquitin-related genes, a four-gene signature was successfully constructed to evaluate the prognosis of patients with HCC. UBE2S was identified in this signature with the potential to predict the survival of patients with HCC. E2F2 transcriptionally upregulated UBE2S expression by directly binding to its promoter. UBE2S positively regulated glycolysis in a HIF-1α-dependent manner, thus promoting the proliferation of HCC cells. Mechanistically, UBE2S enhanced K11-linkage polyubiquitination at lysine residues 171 and 196 of VHL independent of E3 ligase, thereby indirectly stabilizing HIF-1α protein levels by mediating the degradation of VHL by the proteasome. In particular, the combination of cephalomannine, a small molecule compound that inhibits the expression of UBE2S, and PX-478, an inhibitor of HIF-1α, significantly improved the anti-tumor efficacy.
Conclusions UBE2S is identified as a key biomarker in HCC among the thousands of ubiquitin-related genes and promotes glycolysis by E3 enzyme-independent ubiquitination, thus serving as a therapeutic target for the treatment of HCC.
Citations
Citations to this article as recorded by
High mobility group protein N2 inhibits the progression of hepatocellular carcinoma and the related molecular mechanisms Gang Li, Guanbo Zhang, Jinsong Li, Jie Zhang, Zhi Yang, Lin Yang, Jiaxing Wang Cytotechnology.2025;[Epub] CrossRef
UBE2S: A novel driver of HIF-1alpha-induced metabolic reprogramming in hepatocellular carcinoma: Editorial on “UBE2S promotes glycolysis in hepatocellular carcinoma by enhancing E3 enzyme-independent polyubiquitination of VHL” Martina Mang Leng Lei, Terence Kin Wah Lee Clinical and Molecular Hepatology.2025; 31(1): 281. CrossRef
Reply to correspondence on “UBE2S: A novel driver of HIF-1alpha-induced metabolic reprogramming in hepatocellular carcinoma” Martina Mang Leng Lei, Terence Kin Wah Lee Clinical and Molecular Hepatology.2025; 31(1): e119. CrossRef
Correspondence to letter to the editor 1 on “Conventional and machine learning-based risk scores for patients with early-stage hepatocellular carcinoma” Chun-Ting Ho, Elise Chia-Hui Tan, Chien-Wei Su Clinical and Molecular Hepatology.2025; 31(1): e96. CrossRef
Correspondence to editorial on “UBE2S promotes glycolysis in hepatocellular carcinoma by enhancing E3 enzyme-independent polyubiquitination of VHL” Renyu Zhang, Ding Wei, Zhinan Chen, Huijie Bian Clinical and Molecular Hepatology.2025; 31(1): e58. CrossRef
Ubiquitin-conjugating enzyme E2S decreases the sensitivity of glioblastoma cells to temozolomide by upregulating PGAM1 via the interaction with OTUB2 Lin Xu, Baoju Wang, Zhenbo Gang, Zhibin Han, Aowen Wang, Qi Liu, Hongyang Liu, Shilong Wei, Zhiguo Lin, Chuncheng Xie, Li Hu International Journal of Biological Macromolecules.2025; 302: 140583. CrossRef
In Silico Discovery and Screening of Small Molecule Inhibitors Targeting Glyceraldehyde-3-Phosphate Dehydrogenase ~ Triosephosphate Isomerase Protein Complex Towards New Anti-Schistosomal Drug Development Kagiso Motlhatlhedi, Mustafa Alhaji Isa, Tshepang Ndaba, Abidemi Paul Kappo Chemistry Africa.2025; 8(7): 2897. CrossRef
Establishment of human trophoblast stem cells from term smooth chorion Takako Hoshiyama, Masanaga Muto, Shoma Matsumoto, Eiichi Okamura, Bat-Erdene Jargalsaikhan, Takashi Murakami, Shunichiro Tsuji, Masatsugu Ema Placenta.2025; 169: 114. CrossRef
Correspondence to editorial on “Molecular Classification of Hepatocellular Carcinoma based on Zoned Metabolic Feature and Oncogenic Signaling Pathway.” Tomoko Aoki, Naoshi Nishida, Masatoshi Kudo Clinical and Molecular Hepatology.2025;[Epub] CrossRef
Screening metabolic features of stroke in atrial fibrillation Haiyu Zhang, Siqi Zhai, Xiangyuan Gao, Guosheng Wang, Jiale Yang, Mengjie Wang, Xinyuan Zhang, Hansen Yang, Tongshuai Zhang, Fan Zhang Analytica Chimica Acta.2025; 1375: 344576. CrossRef
Stemness- and hypoxia-based prognostic stratification index reveals G6PD as a regulator of hypoxia-driven stemness in hepatocellular carcinoma Mingwei Gao, Yuechuan Liu, Jianhui Wu, Peiru Zhang, Jin Liu, Kun Guo, Binwen Sun, Sunbin Ling, Liming Wang Frontiers in Immunology.2025;[Epub] CrossRef
Post-translational modifications in hepatocellular carcinoma: mechanisms and therapeutic potential Jianqi Qin, Weixiong Zhu, Zengxi Yang, Shuze Zhang, Wence Zhou Medical Oncology.2025;[Epub] CrossRef
Posttranslational modifications in Helicobacter pylori-associated gastric pathogenesis: Bridging inflammation and carcinogenesis Wei Li, Tong Liu, Tianhua Wu, Ting Cai, Fen Wang, Minglin Zhang Biochimica et Biophysica Acta (BBA) - Reviews on Cancer.2025; 1880(6): 189492. CrossRef
Mechanisms of ferroptosis in primary hepatocellular carcinoma and progress of artificial intelligence-based predictive modeling in hepatocellular carcinoma Jiang-Feng Han, Zi-Yao Jia, Xiang Fan, Xue-Yan Zhao, Li-Ye Cheng, Yu-Xuan Xia, Xiao-Ran Ji, Wen-Qiao Zang World Journal of Gastroenterology.2025;[Epub] CrossRef
First
Prev
